Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ipsen
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female patients ≥18 years of age
Patients with solid tumours who have received at least one line of therapy for advanced disease
Measurable or non-measurable evaluable disease per RECIST 1.1
Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) ≤1
Standard of care and/or any investigational therapies must have been completed at least 3 weeks prior to treatment
You may not be if
Prior malignancy within the previous 2 years except for locally curable cancers that have been cured, such as basal or squamous cell skin cancer, or carcinoma in situ of the cervix, breast or bladder
Known primary central malignancy or symptomatic central nervous system metastasis
Major surgical intervention within 28 days before study drug administration
